Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Outcomes in women with invasive ductal or invasive lobular early stage breast cancer treated with anastrozole or exemestane in CCTG (NCIC CTG) MA.27.

Strasser-Weippl K, Sudan G, Ramjeesingh R, Shepherd LE, O'Shaughnessy J, Parulekar WR, Liedke PER, Chen BE, Goss PE.

Eur J Cancer. 2018 Feb;90:19-25. doi: 10.1016/j.ejca.2017.11.014. Epub 2017 Dec 20.

PMID:
29274617
2.

Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer.

Matissek KJ, Onozato ML, Sun S, Zheng Z, Schultz A, Lee J, Patel K, Jerevall PL, Saladi SV, Macleay A, Tavallai M, Badovinac-Crnjevic T, Barrios C, Beşe N, Chan A, Chavarri-Guerra Y, Debiasi M, Demirdögen E, Egeli Ü, Gökgöz S, Gomez H, Liedke P, Tasdelen I, Tolunay S, Werutsky G, St Louis J, Horick N, Finkelstein DM, Le LP, Bardia A, Goss PE, Sgroi DC, Iafrate AJ, Ellisen LW.

Cancer Discov. 2018 Mar;8(3):336-353. doi: 10.1158/2159-8290.CD-17-0535. Epub 2017 Dec 14.

PMID:
29242214
3.

Real world patterns of care in HER2-overexpressing breast cancer: Results of a survey of TEACH clinical trial investigators in 2011.

Chavarri-Guerra Y, St Louis J, Bukowski A, Soto-Perez-de-Celis E, Liedke PER, Symecko H, Moy B, Higgins M, Finkelstein DM, Goss PE.

Breast. 2017 Feb;31:197-201. doi: 10.1016/j.breast.2016.11.014. Epub 2016 Nov 25.

PMID:
27894048
4.

P1.36: Non-Small-Cell Lung Cancer and Brain Metastases in Brazil: Track: Advanced NSCLC.

Weis LN, Coelho JC, Marks P, Geib G, Liedke P, Pereira R, Schwartsmann G, Azevedo S.

J Thorac Oncol. 2016 Oct;11(10S):S204-S205. doi: 10.1016/j.jtho.2016.08.058. Epub 2016 Sep 22. No abstract available.

5.

New onset vasomotor symptoms but not musculoskeletal symptoms associate with clinical outcomes on extended adjuvant letrozole - Analyses from NCIC CTG MA.17.

Liedke PE, Tu D, Shepherd L, Chavarri-Guerra Y, Pritchard KI, Stearns V, Goss PE.

Breast. 2016 Jun;27:99-104. doi: 10.1016/j.breast.2016.02.010. Epub 2016 Apr 5.

PMID:
27058233
6.

Progress and remaining challenges for cancer control in Latin America and the Caribbean.

Strasser-Weippl K, Chavarri-Guerra Y, Villarreal-Garza C, Bychkovsky BL, Debiasi M, Liedke PE, Soto-Perez-de-Celis E, Dizon D, Cazap E, de Lima Lopes G Jr, Touya D, Nunes JS, St Louis J, Vail C, Bukowski A, Ramos-Elias P, Unger-Saldaña K, Brandao DF, Ferreyra ME, Luciani S, Nogueira-Rodrigues A, de Carvalho Calabrich AF, Del Carmen MG, Rauh-Hain JA, Schmeler K, Sala R, Goss PE.

Lancet Oncol. 2015 Oct;16(14):1405-38. doi: 10.1016/S1470-2045(15)00218-1. Review.

PMID:
26522157
7.

Treatment-associated musculoskeletal and vasomotor symptoms and relapse-free survival in the NCIC CTG MA.27 adjuvant breast cancer aromatase inhibitor trial.

Stearns V, Chapman JA, Ma CX, Ellis MJ, Ingle JN, Pritchard KI, Budd GT, Rabaglio M, Sledge GW, Le Maitre A, Kundapur J, Liedke PE, Shepherd LE, Goss PE.

J Clin Oncol. 2015 Jan 20;33(3):265-71. doi: 10.1200/JCO.2014.57.6926. Epub 2014 Dec 15.

8.

Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy.

Chavarri-Guerra Y, Higgins MJ, Szymonifka J, Cigler T, Liedke P, Partridge A, Ligibel J, Come SE, Finkelstein D, Ryan PD, Goss PE.

Br J Cancer. 2014 Nov 25;111(11):2046-50. doi: 10.1038/bjc.2014.502. Epub 2014 Sep 18.

9.

Access to care issues adversely affect breast cancer patients in Mexico: oncologists' perspective.

Chavarri-Guerra Y, St Louis J, Liedke PE, Symecko H, Villarreal-Garza C, Mohar A, Finkelstein DM, Goss PE.

BMC Cancer. 2014 Sep 9;14:658. doi: 10.1186/1471-2407-14-658.

10.

Challenges to effective cancer control in China, India, and Russia.

Goss PE, Strasser-Weippl K, Lee-Bychkovsky BL, Fan L, Li J, Chavarri-Guerra Y, Liedke PE, Pramesh CS, Badovinac-Crnjevic T, Sheikine Y, Chen Z, Qiao YL, Shao Z, Wu YL, Fan D, Chow LW, Wang J, Zhang Q, Yu S, Shen G, He J, Purushotham A, Sullivan R, Badwe R, Banavali SD, Nair R, Kumar L, Parikh P, Subramanian S, Chaturvedi P, Iyer S, Shastri SS, Digumarti R, Soto-Perez-de-Celis E, Adilbay D, Semiglazov V, Orlov S, Kaidarova D, Tsimafeyeu I, Tatishchev S, Danishevskiy KD, Hurlbert M, Vail C, St Louis J, Chan A.

Lancet Oncol. 2014 Apr;15(5):489-538. doi: 10.1016/S1470-2045(14)70029-4.

PMID:
24731404
11.

Intermittent letrozole therapy for metastatic breast cancer: case reports and literature review.

Fan L, Liedke PE, Isakoff SJ, St Louis J, Ryan PD, Goss PE.

Clin Breast Cancer. 2014 Apr;14(2):e41-5. doi: 10.1016/j.clbc.2013.10.009. Epub 2013 Oct 25. Review. No abstract available.

PMID:
24342729
12.

Outcomes of breast cancer in Brazil related to health care coverage: a retrospective cohort study.

Liedke PE, Finkelstein DM, Szymonifka J, Barrios CH, Chavarri-Guerra Y, Bines J, Vasconcelos C, Simon SD, Goss PE.

Cancer Epidemiol Biomarkers Prev. 2014 Jan;23(1):126-33. doi: 10.1158/1055-9965.EPI-13-0693. Epub 2013 Oct 28.

13.

Reply to e. Esin et al.

Goss PE, Liedke PE, Chapman JA, Shepherd LE.

J Clin Oncol. 2013 Sep 20;31(27):3439-40. doi: 10.1200/JCO.2013.51.4893. Epub 2013 Aug 5. No abstract available.

PMID:
23943834
14.

Planning cancer control in Latin America and the Caribbean.

Goss PE, Lee BL, Badovinac-Crnjevic T, Strasser-Weippl K, Chavarri-Guerra Y, St Louis J, Villarreal-Garza C, Unger-Saldaña K, Ferreyra M, Debiasi M, Liedke PE, Touya D, Werutsky G, Higgins M, Fan L, Vasconcelos C, Cazap E, Vallejos C, Mohar A, Knaul F, Arreola H, Batura R, Luciani S, Sullivan R, Finkelstein D, Simon S, Barrios C, Kightlinger R, Gelrud A, Bychkovsky V, Lopes G, Stefani S, Blaya M, Souza FH, Santos FS, Kaemmerer A, de Azambuja E, Zorilla AF, Murillo R, Jeronimo J, Tsu V, Carvalho A, Gil CF, Sternberg C, Dueñas-Gonzalez A, Sgroi D, Cuello M, Fresco R, Reis RM, Masera G, Gabús R, Ribeiro R, Knust R, Ismael G, Rosenblatt E, Roth B, Villa L, Solares AL, Leon MX, Torres-Vigil I, Covarrubias-Gomez A, Hernández A, Bertolino M, Schwartsmann G, Santillana S, Esteva F, Fein L, Mano M, Gomez H, Hurlbert M, Durstine A, Azenha G.

Lancet Oncol. 2013 Apr;14(5):391-436. doi: 10.1016/S1470-2045(13)70048-2.

PMID:
23628188
15.

Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial.

Goss PE, Ingle JN, Pritchard KI, Ellis MJ, Sledge GW, Budd GT, Rabaglio M, Ansari RH, Johnson DB, Tozer R, D'Souza DP, Chalchal H, Spadafora S, Stearns V, Perez EA, Liedke PE, Lang I, Elliott C, Gelmon KA, Chapman JA, Shepherd LE.

J Clin Oncol. 2013 Apr 10;31(11):1398-404. doi: 10.1200/JCO.2012.44.7805. Epub 2013 Jan 28.

16.

Extended adjuvant endocrine therapy in hormone dependent breast cancer: the paradigm of the NCIC-CTG MA.17/BIG 1-97 trial.

Higgins MJ, Liedke PE, Goss PE.

Crit Rev Oncol Hematol. 2013 Apr;86(1):23-32. doi: 10.1016/j.critrevonc.2012.09.013. Epub 2012 Oct 30. Review.

PMID:
23116626
17.

Breast cancer in Mexico: a growing challenge to health and the health system.

Chávarri-Guerra Y, Villarreal-Garza C, Liedke PE, Knaul F, Mohar A, Finkelstein DM, Goss PE.

Lancet Oncol. 2012 Aug;13(8):e335-43. doi: 10.1016/S1470-2045(12)70246-2. Review.

PMID:
22846838
18.

Breast cancer in Brazil: present status and future goals.

Lee BL, Liedke PE, Barrios CH, Simon SD, Finkelstein DM, Goss PE.

Lancet Oncol. 2012 Mar;13(3):e95-e102. doi: 10.1016/S1470-2045(11)70323-0. Review.

PMID:
22381937
19.

Aromatase inhibitors and musculoskeletal adverse events.

Liedke PE, Goss PE.

Lancet Oncol. 2012 Apr;13(4):333-4. doi: 10.1016/S1470-2045(11)70345-X. Epub 2012 Jan 20. No abstract available.

PMID:
22265696
20.

Systemic administration of doxorubicin impairs aversively motivated memory in rats.

Liedke PE, Reolon GK, Kilpp B, Brunetto AL, Roesler R, Schwartsmann G.

Pharmacol Biochem Behav. 2009 Dec;94(2):239-43. doi: 10.1016/j.pbb.2009.09.001. Epub 2009 Sep 9.

PMID:
19747935
21.

Successful treatment of AIDS-related Castleman's disease following the administration of highly active antiretroviral therapy (HAART).

Sprinz E, Jeffman M, Liedke P, Putten A, Schwartsmann G.

Ann Oncol. 2004 Feb;15(2):356-8. No abstract available.

PMID:
14760135

Supplemental Content

Loading ...
Support Center